Carefully Selected News and Features About Metastatic Breast Cancer Research
Metastatic Trial Talk empowers you with knowledge about the latest clinical trials, research, and treatment options for you to share and discuss with your doctor.
- LATEST UPDATES>March 2025
FDA Approves Enhertu® for Hormone Receptor-Positive, HER2-Low or HER2-Ultralow MBC
Read about the expanded approval of Enhertu® for some people with HR+, HER2-low or HER2-ultralow MBC based on clinical trial...
Read moreWhat Are Radiopharmaceuticals and How Are They Used in MBC?
Radiopharmaceuticals are drugs attached to radioactive molecules. Click here to learn about their safety and how they are being studied in clinical trials to help diagnose and...
Read moreNew Clinical Trials For Stage IV Breast Cancer
New clinical trials for stage 4 breast cancer are available. See clinical trials for ER or PR positive, HER2 positive or HER2 negative or HER2 Low, Triple Negative and other...
Read moreSide Effects of MBC Treatments: Pain and Neuropathy
This month, we highlight advice from experts about how to manage pain as a side effect, as well as clinical trials that are studying ways to reduce pain. Learn more...
Read moreUpcoming MBC Conferences in March
Learn how to stay updated about several conferences this month for people living with MBC, including opportunities to participate...
Read moreWhat Are Inclusion and Exclusion Criteria?
Together called eligibility criteria, inclusion and exclusion criteria outline who can and cannot participate in a trial. This month we share why these criteria are important, as...
Read moreHow to Prepare for Your Visit With Your Healthcare Team
Learn how to prepare for a doctor’s appointment to help you discuss the topics and questions that are most important to you, which may include clinical...
Read moreSEARCH OUR SITE
for past articles or specific information.